Net Profit Margin
since 2005
Calculation
Illumina Inc., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income (loss) attributable to Illumina stockholders1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 20.25% | = | 100 | × | 656) | ÷ | 3,239) |
| Dec 29, 2019 | 28.28% | = | 100 | × | 1,002) | ÷ | 3,543) |
| Dec 30, 2018 | 24.78% | = | 100 | × | 826) | ÷ | 3,333) |
| Dec 31, 2017 | 26.38% | = | 100 | × | 726) | ÷ | 2,752) |
| Jan 1, 2017 | 19.29% | = | 100 | × | 463) | ÷ | 2,398) |
| Jan 3, 2016 | 20.79% | = | 100 | × | 462) | ÷ | 2,220) |
| Dec 28, 2014 | 18.98% | = | 100 | × | 353) | ÷ | 1,861) |
| Dec 29, 2013 | 8.82% | = | 100 | × | 125) | ÷ | 1,421) |
| Dec 30, 2012 | 13.17% | = | 100 | × | 151) | ÷ | 1,149) |
| Jan 1, 2012 | 8.21% | = | 100 | × | 87) | ÷ | 1,056) |
| Jan 2, 2011 | 13.83% | = | 100 | × | 125) | ÷ | 903) |
| Jan 3, 2010 | 10.85% | = | 100 | × | 72) | ÷ | 666) |
| Dec 28, 2008 | 8.81% | = | 100 | × | 50) | ÷ | 573) |
| Dec 30, 2007 | -75.89% | = | 100 | × | (278) | ÷ | 367) |
| Dec 31, 2006 | 21.65% | = | 100 | × | 40) | ÷ | 185) |
| Jan 1, 2006 | -28.40% | = | 100 | × | (21) | ÷ | 74) |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
The financial trajectory of net profit margins reveals a transition from extreme early-stage volatility to a period of sustained expansion, followed by a recent contraction in profitability.
- Early Volatility and Instability (2006–2008)
- The initial period is characterized by significant fluctuations in the net profit margin, which swung from -28.40% in 2006 to 21.65% in 2006, and then plummeted to -75.89% in 2007. This instability reflects inconsistent net income results during a phase of rapid revenue growth, where costs likely scaled faster than earnings.
- Stabilization and Linear Growth (2009–2013)
- A period of relative stability emerged between 2009 and 2013, with margins consolidating within a range of 8.21% to 13.83%. During this time, revenue increased steadily from 666 million to 1.421 billion, suggesting the establishment of a more predictable operational cost structure.
- Accelerated Margin Expansion (2014–2019)
- Significant profitability improvement is observed starting in 2014, with margins trending upward from 18.98% to a peak of 28.28% in 2019. This indicates strong operating leverage, as net income growth significantly outpaced revenue growth, culminating in a peak net income of 1.002 billion against 3.543 billion in revenue.
- Recent Profitability Contraction (2020)
- A downward shift occurred in 2020, where the net profit margin contracted to 20.25%. This decline corresponds with a reduction in both total revenue, which fell to 3.239 billion, and net income, which decreased to 656 million, marking the first significant retreat in profitability since 2013.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Illumina Inc., net profit margin, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 20.25% | 10.08% | 29.97% | -21.20% | 16.36% | 25.24% | 0.51% | 17.82% | 14.72% | 22.53% | 41.35% | 19.79% | 43.70% |
| Dec 29, 2019 | 28.28% | 23.69% | 35.32% | 13.15% | 16.80% | 37.27% | 24.35% | 18.42% | 21.01% | 31.45% | 26.91% | 14.47% | 28.27% |
| Dec 30, 2018 | 24.78% | 17.36% | 37.25% | 21.81% | 13.33% | 13.16% | 25.16% | 18.75% | 14.71% | 20.79% | 36.42% | 12.06% | 68.80% |
| Dec 31, 2017 | 26.38% | 18.82% | 9.08% | 4.85% | 13.60% | -0.89% | 18.03% | 1.70% | 5.97% | 40.55% | 20.41% | 10.64% | 10.59% |
| Jan 1, 2017 | 19.29% | 23.22% | 35.27% | 22.94% | 15.13% | 12.90% | 45.07% | 23.01% | 9.85% | 13.66% | 18.42% | 11.06% | -6.58% |
| Jan 3, 2016 | 20.79% | 22.50% | 33.13% | 9.45% | 16.33% | 12.07% | 56.32% | 21.99% | 11.25% | 14.25% | 15.50% | 11.64% | -53.89% |
| Dec 28, 2014 | 18.98% | 8.89% | 26.69% | 12.62% | 13.05% | 12.19% | 49.44% | 21.96% | 28.22% | 18.42% | 12.34% | 11.22% | -127.25% |
| Dec 29, 2013 | 8.82% | 21.97% | 27.93% | 15.64% | 14.10% | 20.27% | 28.46% | 19.40% | 10.00% | 42.65% | 20.16% | 9.73% | -36.72% |
| Dec 30, 2012 | 13.17% | 28.70% | 26.11% | 11.12% | 13.10% | 18.09% | 27.57% | 16.14% | 13.05% | 24.70% | 54.43% | 9.42% | -7.01% |
| Jan 1, 2012 | 8.21% | — | 24.08% | 17.46% | 13.50% | 17.90% | 34.60% | 14.87% | 13.05% | 14.84% | -49.74% | 11.34% | 2.10% |
| Jan 2, 2011 | 13.83% | — | 31.56% | 15.92% | 13.58% | 21.97% | 39.26% | 21.65% | 1.87% | 12.18% | -22.76% | 9.60% | -526.35% |
| Jan 3, 2010 | 10.85% | — | 32.09% | 56.42% | 10.30% | 19.82% | 40.74% | 19.82% | 47.04% | 17.27% | -17.88% | 8.41% | -630.27% |
| Dec 28, 2008 | 8.81% | — | 28.57% | 25.47% | 10.38% | -10.17% | 39.55% | 20.31% | 32.74% | 16.78% | -34.69% | 9.47% | -262.02% |
| Dec 30, 2007 | -75.89% | — | 22.12% | 11.19% | 12.42% | 15.85% | 43.27% | 17.31% | 13.54% | 16.82% | -84.46% | 7.81% | -196.61% |
| Dec 31, 2006 | 21.65% | — | 21.29% | 8.85% | 11.69% | 16.97% | -45.98% | 20.73% | 19.59% | 39.98% | -161.30% | 4.46% | -95.63% |
| Jan 1, 2006 | -28.40% | — | 30.56% | 15.62% | 11.24% | 13.52% | 44.99% | 20.61% | 21.04% | 15.76% | -144.19% | 8.48% | -126.43% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2020 | 20.25% | 14.07% |
| Dec 29, 2019 | 28.28% | 23.22% |
| Dec 30, 2018 | 24.78% | 19.82% |
| Dec 31, 2017 | 26.38% | 13.06% |
| Jan 1, 2017 | 19.29% | 20.78% |
| Jan 3, 2016 | 20.79% | 21.17% |
| Dec 28, 2014 | 18.98% | 21.24% |
| Dec 29, 2013 | 8.82% | 21.99% |
| Dec 30, 2012 | 13.17% | 18.53% |
| Jan 1, 2012 | 8.21% | 15.70% |
| Jan 2, 2011 | 13.83% | 15.16% |
| Jan 3, 2010 | 10.85% | 25.73% |
| Dec 28, 2008 | 8.81% | 18.17% |
| Dec 30, 2007 | -75.89% | 15.90% |
| Dec 31, 2006 | 21.65% | 22.24% |
| Jan 1, 2006 | -28.40% | 18.33% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., net profit margin, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Dec 31, 2020 | 20.25% | 10.27% |
| Dec 29, 2019 | 28.28% | 14.56% |
| Dec 30, 2018 | 24.78% | 12.61% |
| Dec 31, 2017 | 26.38% | 9.26% |
| Jan 1, 2017 | 19.29% | 12.80% |
| Jan 3, 2016 | 20.79% | 13.94% |
| Dec 28, 2014 | 18.98% | 14.40% |
| Dec 29, 2013 | 8.82% | 15.04% |
| Dec 30, 2012 | 13.17% | 13.92% |
| Jan 1, 2012 | 8.21% | 12.06% |
| Jan 2, 2011 | 13.83% | 11.90% |
| Jan 3, 2010 | 10.85% | 17.77% |
| Dec 28, 2008 | 8.81% | 13.00% |
| Dec 30, 2007 | -75.89% | 12.52% |
| Dec 31, 2006 | 21.65% | 15.30% |
| Jan 1, 2006 | -28.40% | 14.61% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).